Published November 10, 2015 | Version v1
Patent Open

Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions

  • 1. University of Chicago

Contributors

Patent applicant:

Description

Embodiments of the invention include methods and compositions useful in a vaccination strategy capable of neutralizing HIa to provide immunoprotection against S. aureus pneumonia. In certain aspects the invention includes a HIa with reduced toxicity, represented by a recombinant mutant form of HIa (HlaH35L) in which histidine 35 is convened to leucine, which can be used to abrogate the productive assembly of the toxin and protect a subject from staphylococcal pneumonia.

Files

US9181329.pdf

Files (2.7 MB)

Name Size Download all
md5:02c944ec91fec906d877285af894f978
2.7 MB Preview Download

Additional details

Identifiers

Patent number
US 201313742155 A
Patent application number
US 9181329 B2
Other
oai:uchicago.tind.io:8292

Dates

Patent filed
2013-01-15

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Microbiology, Pediatrics, Medicine